Yangying Zhou

3.3k total citations · 3 hit papers
72 papers, 2.3k citations indexed

About

Yangying Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yangying Zhou has authored 72 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 18 papers in Cancer Research. Recurrent topics in Yangying Zhou's work include RNA modifications and cancer (16 papers), Ferroptosis and cancer prognosis (12 papers) and Perovskite Materials and Applications (12 papers). Yangying Zhou is often cited by papers focused on RNA modifications and cancer (16 papers), Ferroptosis and cancer prognosis (12 papers) and Perovskite Materials and Applications (12 papers). Yangying Zhou collaborates with scholars based in China, United States and Japan. Yangying Zhou's co-authors include Hong Lin, Jianbao Li, Qi Zhang, Lanhua Tang, Hong Zhu, Yu Zhou, Yaxuan Wei, Xuewen Yin, Meiqian Tai and Feng Hao and has published in prestigious journals such as Advanced Materials, Nature Communications and The Journal of Chemical Physics.

In The Last Decade

Yangying Zhou

70 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study

2023 207 citations Yangying Zhou et al. profile →
Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development

2020 144 citations Weiping Su, Guanqiao Liu et al. JCI Insight profile →
Suppressing Halide Segregation via Pyridine‐Derivative Isomers Enables Efficient 1.68 eV Bandgap Perovskite Solar Cells

2024 76 citations Yangying Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yangying Zhou China	28	853	678	486	330	308	72	2.3k
Jinhua Zhou China	33	1.0k 1.2×	725 1.1×	394 0.8×	579 1.8×	303 1.0×	124	2.8k
Xiaojing Zhao China	28	1.1k 1.3×	176 0.3×	465 1.0×	331 1.0×	93 0.3×	115	3.0k
Yanjing Li China	28	1.2k 1.4×	165 0.2×	352 0.7×	331 1.0×	75 0.2×	116	2.3k
Chenchen Lü China	17	724 0.8×	723 1.1×	242 0.5×	146 0.4×	103 0.3×	48	2.0k
Ye Cheng China	18	634 0.7×	144 0.2×	151 0.3×	225 0.7×	89 0.3×	63	1.3k
Yang Xiang China	34	2.0k 2.4×	711 1.0×	337 0.7×	1.1k 3.2×	116 0.4×	156	3.8k
Jinge Zhao China	21	636 0.7×	199 0.3×	215 0.4×	138 0.4×	48 0.2×	112	1.6k
Chunyu Zhang China	22	823 1.0×	132 0.2×	572 1.2×	225 0.7×	118 0.4×	118	2.3k
Lan Ma China	29	993 1.2×	209 0.3×	495 1.0×	139 0.4×	30 0.1×	134	2.4k

Countries citing papers authored by Yangying Zhou

Since Specialization

Citations

This map shows the geographic impact of Yangying Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangying Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangying Zhou more than expected).

Fields of papers citing papers by Yangying Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangying Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangying Zhou. The network helps show where Yangying Zhou may publish in the future.

Co-authorship network of co-authors of Yangying Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yangying Zhou. A scholar is included among the top collaborators of Yangying Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangying Zhou. Yangying Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wen, Xinhua, et al.. (2024). Integrative analysis of multiple cell death model for precise prognosis and drug response prediction in gastric cancer. Discover Oncology. 15(1). 532–532. 2 indexed citations

Nie, Hui, et al.. (2024). The deubiquitinating enzyme ATXN3 promotes hepatocellular carcinoma progression by stabilizing TAZ. Cancer Gene Therapy. 32(1). 136–145.

Li, Xionghui, et al.. (2024). Identification of a novel prognostic signature based on vitamin metabolism clustering-related genes in lung adenocarcinoma. Translational Lung Cancer Research. 13(5). 1084–1100. 2 indexed citations

Ouyang, Lianlian, Yangying Zhou, Weiwei Lai, et al.. (2023). AhR Promotes the Development of Non-small cell lung cancer by Inducing SLC7A11-dependent Antioxidant Function. Journal of Cancer. 14(5). 821–834. 24 indexed citations

He, Fengjiao, Puhua Zeng, Huan Liu, et al.. (2023). Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma. Frontiers in Pharmacology. 14. 1088993–1088993. 5 indexed citations

Zhu, Youwen, Kun Liu, Hong Zhu, Hui Cao, & Yangying Zhou. (2023). Comparative efficacy and safety of novel immuno-chemotherapy for extensive-stage small-cell lung cancer: a network meta-analysis of randomized controlled trial. Therapeutic Advances in Medical Oncology. 15. 2650883–2650883. 5 indexed citations

Li, Xuanxuan, et al.. (2023). Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer. Biomedicines. 11(12). 3165–3165. 8 indexed citations

Cao, Liwei, T. Mamie Lih, Yingwei Hu, et al.. (2022). Characterization of core fucosylation via sequential enzymatic treatments of intact glycopeptides and mass spectrometry analysis. Nature Communications. 13(1). 3910–3910. 28 indexed citations

Zhou, Yangying, et al.. (2022). Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma. Frontiers in Immunology. 13. 994259–994259. 24 indexed citations

10.

Su, Weiping, Guanqiao Liu, Xiaonan Liu, et al.. (2020). Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development. JCI Insight. 5(8). 144 indexed citations breakdown →

11.

Zhou, Yangying, T. Mamie Lih, Jianbo Pan, et al.. (2020). Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets. Journal of Hematology & Oncology. 13(1). 170–170. 37 indexed citations

12.

Zhou, Yangying, Weiming Yang, Minghui Ao, et al.. (2020). Proteomic Analysis of the Air-Way Fluid in Lung Cancer. Detection of Periostin in Bronchoalveolar Lavage (BAL). Frontiers in Oncology. 10. 1072–1072. 9 indexed citations

13.

Yan, Yuanliang, Zhijie Xu, Long Qian, et al.. (2019). Identification of CAV1 and DCN as potential predictive biomarkers for lung adenocarcinoma. American Journal of Physiology-Lung Cellular and Molecular Physiology. 316(4). L630–L643. 46 indexed citations

14.

Chen, Shao‐Yung, Mingming Dong, Ganglong Yang, et al.. (2019). Glycans, Glycosite, and Intact Glycopeptide Analysis of N-Linked Glycoproteins Using Liquid Handling Systems. Analytical Chemistry. 92(2). 1680–1686. 32 indexed citations

15.

Feng, Yuhua, Jinguan Lin, Yiping Liu, et al.. (2019). Investigation of expressions of PDK1, PLK1 and c‐Myc in diffuse large B‐cell lymphoma. International Journal of Experimental Pathology. 100(1). 32–40. 16 indexed citations

16.

Zhou, Yangying, Zhijie Xu, Wei Lin, et al.. (2019). Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes. Frontiers in Oncology. 9. 683–683. 37 indexed citations

17.

Tai, Meiqian, Yu Zhou, Xuewen Yin, et al.. (2019). In situ formation of a 2D/3D heterostructure for efficient and stable CsPbI₂Br solar cells. Journal of Materials Chemistry A. 7(39). 22675–22682. 72 indexed citations

18.

Wang, Xiang, Yuanliang Yan, Xi Chen, et al.. (2018). The Antitumor Activities of Marsdenia tenacissima. Frontiers in Oncology. 8. 473–473. 44 indexed citations

19.

Tang, Youhong, Hui Zhou, Yiping Liu, et al.. (2017). STAT3 mediates multidrug resistance of Burkitt lymphoma cells by promoting antioxidant feedback. Biochemical and Biophysical Research Communications. 488(1). 182–188. 14 indexed citations

20.

Xiao, Desheng, Yangying Zhou, Chunyan Fu, et al.. (2017). Lymphoepithelioma is a nonkeratinizing squamous cell carcinoma with Epstein–Barr virus infection in China. Journal of Cancer Research and Therapeutics. 13(5). 807–807. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact